Elekta Neuromag outsources magnetoencephalography production to Innokas
11 May 2007
Stockholm, Sweden. Elekta Neuromag Oy, the Finnish subsidiary of the Swedish
Elekta Group (STO:EKTAB), and Innokas Medical Oy, a Finnish private company,
have signed an agreement covering production of the Elekta Neuromag
magnetoencephalography (MEG) system.
The Elekta Neuromag MEG system is used for non-invasive real-time
measurements of brain activity. The production, including the employees
involved, will be transferred to Innokas Medical during 2007.
reinforcing its operations in the MEG business area due to the changing
market situations and the increased need for its MEG technology. By
outsourcing its MEG production to Innokas Medical, Elekta will get the
benefit of a flexible and expert medical equipment production partner, while
keeping the overall technical responsibility of the MEG system towards the
customer. Elekta will continue to invest in innovation and fulfilling the
customers' needs in the MEG area.
For Innokas Medical, this agreement is
an important step in its growth strategy. It will strengthen the company's
position as a leading medical equipment contract manufacturer in Finland.
“Non-invasive, real-time brain mapping and monitoring is considered as one
of the most exciting developments in neuroscience today and the list of new
applications for MEG is steadily growing and the number of installations are
increasing,” said Tomas Puusepp, President and CEO of Elekta. “Elekta is the
only MEG vendor on the market with the financial stability needed to be
committed to the long-term development of MEG technology and our production
outsourcing agreement with Innokas Medical further strengthen our ability to
serve neuroscience centres around the world with leading MEG technology.”